Skip to content

COGT - Cogent Biosciences Inc - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchC

Cogent Biosciences Inc

COGT · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

C

COGTCogent Biosciences Inc

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $43.73
52-wk low: $11.60
Prev close: $27.12
Mkt cap: $6.13B
Beta: 0.33
P/S: 861.1x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$2.2B

SD
Stanley Druckenmiller
Q4 2025 13F
$78.7M
position
AL
Alger
Q2 2026 13F

Earnings

Reported Aug 4, 2026

Earnings came in 5.5% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $6.1B

Valuation

P/S861.15
P/B13.67

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: COGT
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $6.13B
Beta: 0.33

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

13.7x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-109.7%

$41.5M

position

JS

Jim Simons

Q2 2026 13F

$38.6M

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for COGT

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.52+5.5%

-$0.55 expected

Next report

What the street expects next

EPS expected

-$0.56

-$0.61 to -$0.48

Revenue expected

$666.7K

9 analysts

Last 30 days

0up1down

Analysts cutting estimates

Estimate drift

+0.01

Change in 30 days

-109.7%

ROA-43.8%

Growth

Beta0.33